A5062393730- Tryptophan and brain disorders
- Amino Acid Enzymes and Metabolism
- Neuroscience and Neuropharmacology Research
- Diet and metabolism studies
- Electrospun Nanofibers in Biomedical Applications
- Graphene and Nanomaterials Applications
- Diabetes and associated disorders
- Electroconvulsive Therapy Studies
- Alzheimer's disease research and treatments
- Nutrition and Health in Aging
- Frailty in Older Adults
- Health Systems, Economic Evaluations, Quality of Life
- Bipolar Disorder and Treatment
- Functional Brain Connectivity Studies
- Advanced NMR Techniques and Applications
- Protein Hydrolysis and Bioactive Peptides
- Gut microbiota and health
- Schizophrenia research and treatment
- Adipose Tissue and Metabolism
- Dementia and Cognitive Impairment Research
- Metabolism and Genetic Disorders
Nathan Kline Institute for Psychiatric Research
2019-2024
New York Psychoanalytic Society and Institute
2021-2022
Columbia University
2019-2022
New York State Psychiatric Institute
2020-2021
Early detection of Alzheimer's disease (AD) is important for timely interventions and developing new treatments. Hippocampus atrophy an early biomarker AD. The hippocampal parenchymal fraction (HPF) a promising measure structural integrity computed from MRI. It to characterize the dependence HPF on covariates such as age sex in normal population enhance its utility biomarker. We measured 4239 MRI scans 340 cognitively (CN) subjects aged 59-89 years AD Neuroimaging Initiative database,...